Gabriele Elbl
Nessuna posizione attualmente
Storia della carriera di Gabriele Elbl
Precedenti posizioni note di Gabriele Elbl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MORPHOSYS AG | Consigliere Generale | 19/12/2013 | 01/10/2018 |
| THOR MEDICAL | Consigliere Generale | 01/11/2019 | - |
| HEIDELBERG PHARMA AG | Consigliere Generale | 28/05/2010 | - |
| Corporate Officer/Principal | 27/05/2010 | 28/05/2010 |
Formazione di Gabriele Elbl
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 4 |
| Norvegia | 2 |
Posizioni
| General Counsel | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HEIDELBERG PHARMA AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| Aziende private | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Borsa valori
- Insiders
- Gabriele Elbl
- Esperienza
